Global Positron Emission Tomography PET Scanners Market Size By Type (Full-Ring Pet Scanner, Partial-Ring Pet Scanner), By Application (Hospitals, Diagnostic Centers), By Region, And Segment Forecasts...

The Global Positron Emission Tomography (PET) Scanners Market was valued at USD 1.3 billion in 2023 and is projected to reach USD 2.5 billion by 2031, growing at a CAGR of 8.6% during the forecast period of 2023–2031. PET scanners are increasingly vital in diagnosing and monitoring various diseases, particularly in oncology, cardiology, and neurology. The growing prevalence of chronic conditions, coupled with the rising demand for early and accurate diagnosis, is fueling the market's expansion. Additionally, advancements in hybrid imaging technologies such as PET/CT and PET/MRI are further accelerating adoption globally.

Drivers:

1. Rising Prevalence of Chronic Diseases:

The increase in cancer, cardiovascular, and neurological disorders globally is a significant driver. PET imaging offers high sensitivity and precise functional imaging, making it indispensable in early disease detection and treatment planning.

2. Technological Advancements in Imaging Modalities:

The development of hybrid PET systems (like PET/CT and PET/MRI) enhances diagnostic accuracy by combining anatomical and functional imaging. Innovations in radiotracers and detector technologies are further improving image quality and operational efficiency.

3. Growing Demand for Personalized Medicine:

The push toward precision healthcare is bolstering the need for advanced diagnostic tools like PET scanners. These devices support tailored treatment regimens and more effective disease monitoring, aligning with the global shift to value-based care.

Restraints:

1. High Cost of PET Scanners:

The initial acquisition cost, along with maintenance and radiotracer infrastructure requirements, poses a significant barrier, especially for mid-sized healthcare providers and institutions in developing regions.

2. Regulatory and Logistical Challenges:

Strict regulations surrounding radiopharmaceuticals, as well as challenges in distribution due to their short half-life, can hinder widespread adoption, particularly in geographically dispersed areas.

Opportunity:

1. Expansion in Emerging Markets:

Countries in Asia-Pacific, Latin America, and parts of the Middle East are experiencing rapid healthcare infrastructure development, providing untapped opportunities for PET scanner manufacturers.

2. Integration with AI and Machine Learning:

The use of AI to interpret PET images is expected to enhance diagnostic accuracy and workflow efficiency. This integration represents a key opportunity for future product innovation and clinical utility.

Market by System Type Insights:

In 2023, Hybrid PET/CT Scanners held the largest share of the market, owing to their superior diagnostic capabilities in oncology and widespread clinical acceptance. These systems are expected to remain dominant through 2031 due to their dual-imaging advantages. PET/MRI systems, though currently niche, are anticipated to witness the highest growth rate due to their enhanced soft-tissue contrast and reduced radiation exposure, particularly in pediatric and neurological applications.

Market by End-use Insights:

Hospitals and Diagnostic Imaging Centers accounted for the largest market share in 2023. These facilities are major users of PET scanners due to the high patient volume and ability to perform a wide range of diagnostic procedures. The research institutes segment is projected to grow steadily, supported by increasing clinical trials and academic studies using advanced imaging technologies.

Market by Regional Insights:

North America dominated the PET scanner market in 2023, driven by advanced healthcare infrastructure, strong reimbursement frameworks, and the presence of key manufacturers. Asia-Pacific is expected to register the fastest growth during the forecast period, fueled by rising healthcare investments, growing awareness of early diagnosis, and increased adoption of modern diagnostic tools in countries like China and India.

Competitive Scenario:

Key players in the Global PET Scanners Market include GE Healthcare, Siemens Healthineers, Canon Medical Systems Corporation, Philips Healthcare, United Imaging Healthcare, Positron Corporation, Mediso Ltd., and Bruker Corporation. These companies are actively pursuing strategic partnerships, technology upgrades, and global expansions to strengthen their market presence.

Recent Developments:

2023: GE Healthcare launched a new digital PET/CT system with AI-assisted image reconstruction for improved throughput and diagnostic confidence.

2024: Siemens Healthineers expanded its PET/MRI portfolio with a compact, high-resolution model designed for neurological research and pediatric use.

2025: Canon Medical Systems entered a strategic partnership with radiopharmaceutical providers to improve access to PET imaging agents across Asia-Pacific.

Scope of Work – Global Positron Emission Tomography (PET) Scanners Market

Report Metric Details

Market Size (2023) USD 1.3 billion

Projected Market Size (2031) USD 2.5 billion

CAGR (2023–2031) 8.6%

Market Segments System Type (Standalone, Hybrid PET/CT, PET/MRI), End-use